Appearances

• ATVB Journal Session: From Cells to the Clinic: Progress in the Development of Novel Therapeutics for ATVB Diseases
• Clinical Lipidology Update
• Groundbreaking Studies in the Practice of Cardiovascular Medicine
• Cardiovascular Nursing Clinical Symposium
• Device Therapy and Arrhythmia Management in LVAD and Heart Transplant Recipients
• Flipped Classroom: Reviewing (and arguing about) Interesting ECGs
• Working Towards an Expert Consensus for the Management of Acute Type A Dissections: In Collaboration with the Society of Thoracic Surgeons
• Air Pollution and Hypertension
• Aortic Stent Grafts: The Good, The Bad, The Ugly
• Atrial Fibrillation, Stroke, and Intracerebral Hemorrhage: Complex Cases
• Big Data, Small Data: David & Goliath
• Discussion - Big Questions in Gender and Ethnicity in Pulmonary Arterial Hypertension and Peripheral Vascular Disease
• Big Questions in Gender and Ethnicity in Pulmonary Arterial Hypertension and Peripheral Vascular Disease
• Cardiotoxicity of Cancer Therapeutics: Novel Mechanisms
• Controversies in Exercise Training
• Controversies in the Management of Cardiogenic Shock: A Mini-Debate Series
• Diets from Vegan to Ketogenic: What’s the Best for CV Health and for Which Patient?
• Disparities in Heart Failure Care and Treatment: Are We Reaching the Most Vulnerable Patients?
• Epigenetic Mechanisms of Hypertension
• Fact or Fiction: Clinical Controversies in Heart Failure
• Interventional Treatments for Hypertension
• Key Pearls for Success from Diverse Leaders in Cardiovascular Surgery and Anesthesia
• Late Breaking Clinical Trial: Novel Approaches to CV Prevention
• Moving beyond QI Registry Data for Real Cardiovascular Care Improvement
• Navigating Early Career Waters: Mentors, Funding, and Life Balance?
• Neurocardiology: The Brain-Heart Connection
• Neurocognitive Challenges of Adolescents and Emerging Adults with Congenital Heart Disease
• Non-ST-elevation Acute Coronary Syndromes: 2018 and Beyond
• Nurses Improving Outcomes: Overcoming Barriers
• Obesity and HFpEF – Fat, Fitness and Frontiers for Novel Therapeutic Strategies
• Shocking Controversies from the Edge! Saving the Sickest Against All Odds
• Starting and Maintaining a Research Career in Clinical or Population Science
• Structural Heart Disease, 3D imaging, and Artificial Intelligence
• Target BP in Action: A Path to better Blood Pressure Control
• The Swollen Limb: Epidemiology, Diagnosis and Treatment Options
• Thrombosis and Thrombophilia: An Under-Recognized Cardiovascular Concern in Women's Health
• Variability of Blood Pressure and Cardiovascular Disease Risk
• Vasculo-Oncology Crash-Course: How to Handle Vascular Complications in Cancer Patients
• What Every Cardiologist Needs to Know About Comprehensive CV Risk Reduction in Diabetes
• AHA/SCAI Hot Topics in Structural Heart Disease: What's Happening Now? What's Next?
• Communication: Pearls and Perils
• Controversies in Pediatric Cardiology and Cardiac Surgery
• Ethical Dilemmas in Pediatric Cardiac Care
• Innovative Therapies for Heart Recovery: Mechanical Ventricular Unloading
• Interactive Cases on Changing the Paradigm of CV Prevention: Using Lipid Targets, the New Hypertension Guidelines, Novel Glucose-Lowering Therapies, and Coronary Calcium
• Novel Therapies for PAH: The next generation of Clinical Trials
• Resistant Hypertension
• What every Cardiologist needs to know about Vascular Disease and its Management
• Developing Competency-Based Medical Nutrition Education and Training to Advance ASCVD Prevention by Physicians--Leveraging 21st Century Curricula Reforms, Population Health Goals, and NHLBI Roles/Partnerships
• Prevention of Heart Failure- Moving From Theory to Practice
• Reducing Cardiometabolic Risk by Improving Sleep
• Women in Cardiovascular Disease: BYOB (Breakfast) With Women Pioneers Networking Event
• Management of Hypertension in Special Populations
• Can We Develop Therapies to Mimic the Benefits of Exercise?
• Clinical Trials and Challenging Interventional Cases: The 2018 Perspective
• Emerging Concepts about RNA in the Cardiovascular System
• Management of Acute Cardiovascular Disease in Older Adults: The influence of multi-morbidity and frailty in the Coronary Care Unit
• Molecular and Cellular Regulation of Cardiac Inflammation
• Molecular and Metabolic Mechanisms Underlying Cardiomyopathy
• Nursing Science in Review
• Precision Medicine for Heart Failure
• The New Guidelines: Updating Your Practice Patterns, and Avoiding Potential Pitfalls
• Circulation: Cardiovascular Imaging - Editors Picks
• Clinical Management of Familial Hypercholesterolemia
• Meaningful Translational Research: Mouse to Human
• New Technology and Approaches to Arrhythmias: Ablation
• New Technology and Approaches to Arrhythmias: Devices
• State of the Art in Hypertrophic Cardiomyopathy: Beyond the Guidelines
• The 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: What Do You Need To Know?
• Vascular Modeling and Integrated Systems Biology Approaches
• Dilemmas in Antiplatelet Therapy after PCI
• Health Disparities Oral Abstracts
• Immune Cell Communication In Cardiovascular Disease
• Innovations in Secondary Prevention: Case Studies: In Collaboration with the Preventive Cardiovascular Nurses Association
• Delivering PAD Patients Optimal Care Today, Tomorrow and Beyond: Updates in your Therapeutic Armamentarium
• Mentoring and Leadership Perspectives on Gender and Early Career Success
• The Present and Future of Exercise and Interventions for PAD
• The Present and Future of Imaging and Treatment Approaches in PAD
• Recent Progress of Anticoagulation Therapy in Cardiovascular Disease: Joint Session with AHA & The Japanese Circulation Society
• Opening Remarks - Working Towards an Expert Consensus for the Management of Acute Type A Dissections: In Collaboration with the Society of Thoracic Surgeons
• Helen B. Taussig Memorial Lecture
• AF & HFrEF: The Great Debates
• Co-management of Patients with Diabetes and Heart Disease
• Effective Clinical Strategies to Reduce Obesity and Cardiometabolic Risk: Interactive Case Discussions
• Falling Out of Orbita: Lessons from a Provocative Randomized Clinical Trial
• Late Breaking Clinical Trial: Answers to Critical Questions in Cardiovascular Prevention
• Planning for the Urgency of Aging: What Do We Know About Optimal Care for the Very Elderly With Cardiovascular Disease?
• Population Screening for Atrial Fibrillation: Opportunities and Challenges
• Rx for Behavior Change: Engaging Patients to Meet Guidelines
• The Metabolic Face of Heart Failure
• U.S. Health Policy at the Crossroads: What Cardiovascular Clinicians Need to Know
• Unpacking the Cardiovascular Biology of Violence
• You Are What You Eat: The Intestinal Microbiome and Cardiometabolic Disease
• Zip Codes are More Important than Genetic Codes: Social and Environmental Determinants of CVD Risk
• Challenges in Anticoagulation and Stroke Prevention for AF
• Inherited Arrhythmia Challenges: An Updated Case-based Approach
• Prevention Beyond the Guidelines: What to Do Next
• Part I: Cerebral Protection Strategies: the Debate Continues
• Paul Dudley White International Lecture & Session
• Paul Dudley White International Lecture & Session
• PLACEHOLDER - Cholesterol Deep Dive Session
• PLACEHOLDER - Cholesterol Deep Dive Session
• Presidential Session
• Presidential Session
• Cardiovascular Disease and Breast Cancer
• EHR 3.0: The Future of Electronic Health Records
• #SoMe #AHA - Leveraging Social Media in Cardiovascular Medicine
• Debates in Cardiovascular Care: Making Arguments Great Again (#MAGA)
• Next Generation Phenotyping for Cardiovascular and Stroke Research
• State of the Heart For Women: Top Ten Advances in Gender-Specific Medicine
• Advanced Imaging of Coronary Artery Disease: Joint Session with AHA & the European Society of Cardiology (ESC)
• AF 2018: Pushing the Excellence Envelope: Joint Session with AHA & Heart Rhythm Society (HRS)
• Animal Models and Translational Insights
• Cardiac Ion Channels in Disease
• Cardiovascular Disease Prevention: Clinical Advice from Population Studies: Joint Session with AHA & the European Society of Cardiology (ESC)
• Dilated Cardiomyopathy (DCM) As A Dynamic Disease: Evolving Concepts and Management Strategies: Joint Session with AHA & the Brazilian Society of Cardiology
• Does This Patient Have an Indication for an ICD?
• Enhancing Reproducibility: Initiatives and Practical Tools
• Epigenetics of Cardiac Resilience to Stress
• Extracellular Matrix: Fibroblasts and More
• Global Roundtable: Acute Coronary Syndromes from Across the World (AHA, National Heart Foundation Hospital and Research Institute of Bangladesh, Argentine Society of Cardiology & Argentine Federation of Cardiology)
• Global Roundtable: Advances in Interventional Therapies for AS and Complex Coronary Artery Disease: AHA, Israel Heart Society, Heart and Health Foundation of Turkey, & French Society of Cardiology
• Global Roundtable: Are the Millennials (ages 15-35 years) Cardiovascular Disease Time Bombs?: AHA, Italian Association of Hospital Cardiologists, Chilean Society of Cardiology & The Danish Society of Cardiology
• Global Roundtable: Combating the Global Epidemic of Heart Failure: AHA, Gulf Heart Association, Polish Cardiac Society, Singapore Cardiac Society, & Pan African Society of Cardiology
• Global Roundtable: Comparative Effectiveness Echo-MR-Nucs 2018: AHA, European Association of Nuclear Medicine & Saudi Society of Echocardiography
• Global Roundtable: Global Efforts to Accelerate Research in Pediatric Cardiology: AHA, Mexican Society of Cardiology & Japanese Society of Pediatric Cardiology and Cardiac Surgery
• Global Roundtable: Preventing Atrial Fibrillation and Poor Outcomes: What Worldwide Data Teaches: AHA, Cardiac Society of Australia and New Zealand, Romanian Society of Cardiology & Iranian Heart Association
• Heart Failure Controversies: Perspectives from China: Joint Session with AHA & Great Wall Congress of Cardiology
• Heart Failure with Preserved Ejection Fraction: From Bench to Bedside
• His Bundle Pacing: In Sync Again
• How to Handle Device: Related Complications
• How to Manage Vasovagal Syncope and Other Cardiovascular Autonomic Disorders
• Key Issues in Global Advocacy for Rheumatic Heart Disease: Joint Session with AHA & the World Heart Federation
• Latin America at High Cardiovascular Risk: Quo Vadis in the Management of Cardiovascular Risk Control: Joint Session with AHA & the Interamerican Society of Cardiology
• Lipoprotein Metabolism and Atherosclerosis Update
• Lipoprotein(a): From Genes to Disease to Treatment
• Mechanisms of Cardiac Repair and Regeneration
• Metabolic and Oxidative Stress in Cardiovascular Disease
• Mitochondria in Cardiovascular Health and Disease I
• Mitochondria in Cardiovascular Health and Disease II
• New Concepts About Reactive Oxygen and Nitrogen Species as Signaling Molecules in the Myocardium
• New Guidelines in Arrhythmia Management: How Should These Change Patient Care?
• Novel Mechanisms of Cardiac Lineage Commitment
• Novel Small Molecule Drug Development
• Omics and Big Data in Cardiovascular Disease
• Proteostasis Meets Protein Trafficking in the Heart
• Rapid Fire Genomic and Precision Medicine
• Regulatory Mechanisms of Cardiac Growth and Remodeling
• Revascularization for Ischemic Heart Disease: The Right Time, the Right Way and the Right Place: Joint Session with AHA & the American College of Cardiology (ACC)
• Role of T-cells in Myocardial Health and Disease
• Shedding Light on the Dark Genome: Noncoding RNAS in Cardiovascular Homeostasis and Disease
• Smooth Muscle Cell Regulation in cardiovascular Disease
• Taking A Closer Look at Heart Failure in the Middle East: Joint Session with AHA & the Emirates Cardiac Society
• The Crossroads Between Cardiovascular Disease and Bioengineering
• Translational Studies in Cardiac Fibrosis
• Q & A Discussion 3 - Device Therapy and Arrhythmia Management in LVAD and Heart Transplant Recipients
• Rebuttal 1 - AF & HFrEF: The Great Debates
• Hypertension Guidelines: Consensus or Controversy?
• Sharpening The Lens On CV Symptom Management
• Big Data: Opportunities for Nurses
• Engaging Patient-Caregiver Dyads in the Management of Cardiovascular Disease
• Challenging Issues and Emerging Therapies in the Management of Sexual Dysfunction and CVD
• State of the Art Cardiovascular Care
• State of the Art Cardiovascular Care
• Young at Heart: Mechanisms Underlying Cardiac Aging - Q&A 1
• ZNA vs. DNA: How Important Is Zip Code In Care Planning? - Introduction
• ZNA vs. DNA: How Important Is Zip Code In Care Planning?
• Cognition Across the Lifespan: The Heart-Brain Connection - Introduction
• Cognition Across the Lifespan: The Heart-Brain Connection
• Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease - Q&A 1
• Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease
• Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease - Q&A 2
• Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease - Q&A 3
• Crosstalk Between Lipids and Immune Cells in Cardiovascular Disease - Q&A 4
• Value in Healthcare: Transforming Cardiovascular Care - Mark McClellan - Moderator
• Value in Healthcare: Transforming Cardiovascular Care
• Value in Healthcare: Transforming Cardiovascular Care - Nancy Brown - Moderator
• Value in Healthcare: Transforming Cardiovascular Care - Mark McClellan - Speaker - <b><i>The Value in Healthcare Initiative: Answering the Call to Action </i></b>
• Value in Healthcare: Transforming Cardiovascular Care - Nancy Brown - Speaker - The American Heart Association Answers the Call
• Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology - Q&A 1
• Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology
• Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology - Q&A 2
• Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology - Q&A 3
• Care for The Athletic Heart: Many Issues, One Goal: AHA Joint Session with American College of Cardiology - Q&A 4
• Arrhythmia Management in 2019: AHA Joint Session with Iranian Heart Association - Q&A 1
• Arrhythmia Management in 2019: AHA Joint Session with Iranian Heart Association - Q&A 2
• Arrhythmia Management in 2019: AHA Joint Session with Iranian Heart Association - Q&A 3
• Reducing the Global Burden of Cardiovascular Disease: AHA Joint Session with World Heart Federation - Q&A
• Reducing the Global Burden of Cardiovascular Disease: AHA Joint Session with World Heart Federation
• Cardiometabolic Disorders in Migrant Populations AHA Joint Session with Emirates Cardiac Society - Q&A
• Cardiometabolic Disorders in Migrant Populations AHA Joint Session with Emirates Cardiac Society
• Cardiac Remodeling Is All About Metabolism - Q&A 1
• Cardiac Remodeling Is All About Metabolism
• Cardiac Remodeling Is All About Metabolism - Q&A 3
• Cardiac Remodeling Is All About Metabolism - Q&A 4
• Cardiac Remodeling Is All About Metabolism - Q&A 5
• Trending Topics in Population Science - Q&A
• Trending Topics in Population Science
• Transatlantic Perspective on Unanswered Questions in Cardiac Critical Care: Joint AHA/ESC-ACCA - Rapid-Fire debate: Controversies in Management of Post-Cardiac Arrest Syndrome
• Transatlantic Perspective on Unanswered Questions in Cardiac Critical Care: Joint AHA/ESC-ACCA
• Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 1
• Cardiac Morphogenesis and Implications in Congenital Heart Disease
• Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 2
• Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 3
• Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 4
• Cardiac Morphogenesis and Implications in Congenital Heart Disease - Q & A 5
• What Are We Doing About Rare Cardiovascular Diseases?
• What Are We Doing About Rare Cardiovascular Diseases? - Q & A 2
• What Are We Doing About Rare Cardiovascular Diseases? - Q & A 3
• What Are We Doing About Rare Cardiovascular Diseases? - Q & A 5
• Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 1
• Making Spare Parts - Engineered Tissue for Cardiac Repair
• Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 2
• Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 3
• Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 4
• Making Spare Parts - Engineered Tissue for Cardiac Repair - Q & A 5
• Atrial Fibrillation: How to Manage Complex Clinical Scenarios - Q & A 2
• Atrial Fibrillation: How to Manage Complex Clinical Scenarios - Q & A 3
• Atrial Fibrillation: How to Manage Complex Clinical Scenarios - Q & A 4
• Frontiers in Vascular Regeneration - Q&A 2
• Frontiers in Vascular Regeneration - Q&A 3
• Frontiers in Vascular Regeneration - Q&A 4
• Preparing for Success in Early Career - Q&A 1
• Preparing for Success in Early Career
• Publish or Perish? Rules to Live by for Early Career Authors - Session Overview
• Publish or Perish? Rules to Live by for Early Career Authors
• Publish or Perish? Rules to Live by for Early Career Authors - Kathleen A. Dracup Early Career Distinguished Award Lecture
• Mechanical Hemodynamic Support for Cardiogenic Shock in the Modern Era - Introduction
• Mechanical Hemodynamic Support for Cardiogenic Shock in the Modern Era
• Mechanical Hemodynamic Support for Cardiogenic Shock in the Modern Era - Q&A
• Why Doesn't My Patient Respond to Exercise? Gleaning Insights from Failures - Q&A 1
• Why Doesn't My Patient Respond to Exercise? Gleaning Insights from Failures
• PechaKucha Potpourri: The Key Things You Need to Know about Interesting Cardiomyopathies
• Understanding the Link Between Adiposity and Heart Failure - Q&A 1
• Managing Cardiovascular Risk in Diabetes: Ask the Experts and Challenging Cases - Q & A
• Managing Cardiovascular Risk in Diabetes: Ask the Experts and Challenging Cases
• Past Is Prologue: Recent, Ongoing and Future PAH Clinical Trials - Moderated Debate
• Past Is Prologue: Recent, Ongoing and Future PAH Clinical Trials
• Can We Prescribe a Healthy Old Age? - Audience Q&A
• Can We Prescribe a Healthy Old Age?
• Real Life Case Demonstrations - What Happens in the EP Lab Doesn't Stay in the EP Lab - Q&A 1
• Real Life Case Demonstrations - What Happens in the EP Lab Doesn't Stay in the EP Lab
• Real Life Case Demonstrations - What Happens in the EP Lab Doesn't Stay in the EP Lab - Q&A 2
• Real Life Case Demonstrations - What Happens in the EP Lab Doesn't Stay in the EP Lab - Q&A 3
• 3CPR: Shark Tank Style - Q&A 1
• 3CPR: Shark Tank Style
• 3CPR: Shark Tank Style - Q&A 2
• 3CPR: Shark Tank Style - Q&A 3
• 3CPR: Shark Tank Style - Q&A 4
• 3CPR: Shark Tank Style - Q&A 5
• New Insights into Stroke in Atrial Fibrillation - Q&A
• New Insights into Stroke in Atrial Fibrillation
• Cellular Lipids and Circulating Lipoproteins in Atherosclerosis - Q&A 1
• Cellular Lipids and Circulating Lipoproteins in Atherosclerosis
• Cellular Lipids and Circulating Lipoproteins in Atherosclerosis - Q&A 2
• Cellular Lipids and Circulating Lipoproteins in Atherosclerosis - Q&A 3
• Cellular Lipids and Circulating Lipoproteins in Atherosclerosis - Q&A 4
• AHA's Strategic Goals in 2019 and Beyond (Part 1) - Group Reports
• AHA's Strategic Goals in 2019 and Beyond (Part 1)
• Application of Epidemiologic Methods to Address Controversies in Care, Disease Burden and Policy - Q & A
• Application of Epidemiologic Methods to Address Controversies in Care, Disease Burden and Policy
• Atrial Fibrillation: Debates and Controversies
• Atrial Fibrillation: From Wearables to Guidelines - Q & A
• Atrial Fibrillation: From Wearables to Guidelines
• Cardiovascular Nursing Clinical Symposium
• Cardiovascular Nursing Clinical Symposium - Q&A 3
• Cardiovascular Nursing Clinical Symposium - Q & A 4
• Cardiovascular Nursing Clinical Symposium - Q&A 5
• Cardiovascular Nursing Clinical Symposium - Q & A 6
• Cardiovascular Nursing Clinical Symposium - Q&A 7
• Cardiovascular Nursing Clinical Symposium - Q & A 8
• Paul Dudley White International Lecture and Session - Audience Q & A
• Paul Dudley White International Lecture and Session
• Novel Concepts in Cardio-Oncology - Q&A 1
• Novel Concepts in Cardio-Oncology
• Novel Concepts in Cardio-Oncology - Q&A 2
• Novel Concepts in Cardio-Oncology - Q&A 3
• Cardio-Oncology Debates - Vote 1
• Cardio-Oncology Debates
• Cardio-Oncology Debates - Vote 2
• Cardio-Oncology Debates - Vote 3
• Current Advances in International Issues: Joint Session with AHA and Chinese Society of Cardiology - Q&A 1
• Current Advances in International Issues: Joint Session with AHA and Chinese Society of Cardiology
• Current Advances in International Issues: Joint Session with AHA and Chinese Society of Cardiology - Q&A 3
• Cardiovascular Research Using iPS Cell Technology: Joint Session with AHA and The Japanese Circulation Society - Q&A 1
• Cardiovascular Research Using iPS Cell Technology: Joint Session with AHA and The Japanese Circulation Society
• Cardiovascular Research Using iPS Cell Technology: Joint Session with AHA and The Japanese Circulation Society - Q&A 2
• Guideline Essentials - Top 5 Points from Recent Guideline/Consensus Document You Need to Know - Q&A
• Guideline Essentials - Top 5 Points from Recent Guideline/Consensus Document You Need to Know
• Make Yourself at Home: Bringing Hospital Care to the Home for Pediatric Heart Disease - Introduction
• Make Yourself at Home: Bringing Hospital Care to the Home for Pediatric Heart Disease
• ACS Management in 2019 and Beyond - Case Presentation
• ACS Management in 2019 and Beyond
• Late Breaking Science II: Results for the Ischemia Trials: To Intervene or Not to Intervene - Case Presentation
• Late Breaking Science II: Results for the Ischemia Trials: To Intervene or Not to Intervene
• Late Breaking Science II: Results for the Ischemia Trials: To Intervene or Not to Intervene - Case Revisited
• Late Breaking Science III: Controversies in Contemporary Management of AS
• Gaps in the 2018 Cholesterol Guidelines: The Great Debate(s) - Panel
• Gaps in the 2018 Cholesterol Guidelines: The Great Debate(s)
• Late Breaking Science VI: New Frontiers in Lipid Therapy - Q&A
• Late Breaking Science VI: New Frontiers in Lipid Therapy
• Addressing Essential Gaps in the Care of Patients with Atrial Fibrillation - Q&A 6
• Young at Heart: Mechanisms Underlying Cardiac Aging
• Addressing Essential Gaps in the Care of Patients with Atrial Fibrillation
• Frontiers in Vascular Regeneration
• Understanding the Link Between Adiposity and Heart Failure